{"url_path":"/sec/onc/8-k/2026-06-26/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1651308/0001651308-26-000020-index.html","accession_number":"0001651308-26-000020","cik":"0001651308","ticker":"ONC","issuer_name":"BeOne Medicines Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1651308/0001651308-26-000020-index.html","primary_entity_key":"0001651308","primary_entity_name":"BeOne Medicines Ltd."},"word_count":372,"has_tables":true,"body_markdown":"bgne-20260626\n0001651308false00016513082026-06-262026-06-26\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n_____________________\n\nForm 8-K\n\n______________________\n\nCURRENT REPORT\n\nPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\n\nDate of Report (Date of earliest event Reported): June 26, 2026\n\nBEONE MEDICINES LTD.\n\n(Exact Name of Registrant as Specified in Charter)\n\nSwitzerland\n\n001-37686\n\n98-1209416\n\n(State or Other Jurisdiction of Incorporation)\n\n(Commission File Number)\n\n(I.R.S. Employer Identification Number)\n\nc/o BeOne Medicines I GmbH\nAeschengraben 27\n\nBasel 4051\nSwitzerland\n\n(Address of Principal Executive Offices) (Zip Code)\n\n+41 61 685 19 00\n\n(Registrant's telephone number, including area code)\n\nN/A\n\n(Former name or former address, if changed since last report)\n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading Symbol(s)\n\nName of each exchange on which registered\n\nAmerican Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share\n\nONC\n\nThe Nasdaq Global Select Market\n\nOrdinary Shares, par value $0.0001 per share*\n\n06160\n\nThe Stock Exchange of Hong Kong Limited\n\n*Included in connection with the registration of the American Depositary Shares with the Securities and Exchange Commission. The ordinary shares are not listed for trading in the United States but are listed for trading on The Stock Exchange of Hong Kong Limited.\n\nIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐"}